Revvity (RVTY) Shares Outstanding (Weighted Average) (2009 - 2026)
Revvity (RVTY) reported Shares Outstanding (Weighted Average) of $111.9 million for Q2 2026, down 6.9% on a YoY basis from $120.1 million in Q2 2025, and down 4.02% quarter-over-quarter from $116.5 million in Q4 2025.
Revvity (RVTY) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends
Revvity has reported Shares Outstanding (Weighted Average) for 18 years, with the latest figure at $111.9 million in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Weighted Average) fell 6.9% year-over-year to $111.9 million; the trailing twelve-month figure through Apr 2026 stood at $111.9 million (down 6.9% YoY), and the FY2025 full-year result was $116.5 million, down 5.06% from the prior year.
- Shares Outstanding (Weighted Average) for Q2 2026 stood at $111.9 million, down from $116.5 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $126.3 million in Q2 2023, with the low at $111.9 million in Q2 2026.
- Historically, Shares Outstanding (Weighted Average) has averaged $122.2 million across 5 years, with a median of $123.4 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) advanced 12.62% — and 2026, when it slipped 6.9%.
- Revvity's Shares Outstanding (Weighted Average) stood at $126.2 million in 2022, then declined by 1.15% to $124.7 million in 2023, then retreated by 1.56% to $122.8 million in 2024, then slipped by 5.06% to $116.5 million in 2025, then retreated by 4.02% to $111.9 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $111.9 million (Q2 2026), $116.5 million (Q4 2025), and $117.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 82.14 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 372.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 707.90 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 79.65 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 282.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 168.40 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 141.50 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 153.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 20.29 Mn |
| 10 | Revvity | 11.23 Bn | 10.37 Bn | 387.66 Mn | 111.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 111.85 Mn |
| Dec 28, 2025 | 116.54 Mn |
| Sep 28, 2025 | 117.69 Mn |
| Jun 29, 2025 | 118.82 Mn |
| Mar 30, 2025 | 120.14 Mn |
| Dec 29, 2024 | 122.76 Mn |
| Sep 29, 2024 | 123.20 Mn |
| Jun 30, 2024 | 123.35 Mn |
| Mar 31, 2024 | 123.43 Mn |
| Dec 31, 2023 | 124.70 Mn |
| Oct 1, 2023 | 125.16 Mn |
| Jul 2, 2023 | 125.75 Mn |
| Apr 2, 2023 | 126.29 Mn |
| Jan 1, 2023 | 126.16 Mn |
| Oct 2, 2022 | 126.16 Mn |
| Jul 3, 2022 | 126.13 Mn |
| Apr 3, 2022 | 126.14 Mn |
| Jan 2, 2022 | 116.17 Mn |
| Oct 3, 2021 | 112.84 Mn |
| Jul 4, 2021 | 112.00 Mn |